Vivos (RDGL) Shares Outstanding (Entity) (2010 - 2026)
Vivos (RDGL) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 1.73 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 383.57 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 576.60 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 377.40 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 451.69 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 977.43 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 97.50 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | 455.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 494.21 Mn |
| Dec 31, 2025 | 455.49 Mn |
| Sep 30, 2025 | 454.66 Mn |
| Jun 30, 2025 | 453.80 Mn |
| Mar 31, 2025 | 453.41 Mn |
| Dec 31, 2024 | 440.87 Mn |
| Sep 30, 2024 | 417.59 Mn |
| Jun 30, 2024 | 417.68 Mn |
| Mar 31, 2024 | 390.03 Mn |
| Dec 31, 2023 | 387.89 Mn |
| Sep 30, 2023 | 370.54 Mn |
| Jun 30, 2023 | 370.54 Mn |
| Mar 31, 2023 | 362.54 Mn |
| Dec 31, 2022 | 362.54 Mn |
| Sep 30, 2022 | 359.89 Mn |
| Jun 30, 2022 | 343.91 Mn |
| Mar 31, 2022 | 343.91 Mn |
| Dec 31, 2021 | 343.53 Mn |
| Sep 30, 2021 | 335.78 Mn |
| Jun 30, 2021 | 334.94 Mn |